Devoted to Amyloidosis: AstraZeneca’s Heartfelt Commitment at ISA 2024
AstraZeneca and Alexion will present at the International Symposium on Amyloidosis (ISA) 2024, showcasing studies on their amyloidosis treatment...
Adaptive Clinical Trial Design Adaptive Trial Design Addiction Psychiatry AI in Clinical Trials alcohol use disorder Alzheimer's Disease Article Clinical Operations Clinical Research Clinical Trial Design Clinical Trial Operations Clinical Trial Ops Brief Clinical Trials CLINOPS WATCHDOG CNS Drug Development CNS Trials Conference Coverage CRO Consolidation Decentralized Clinical Trials Digital Health Technologies dual diagnosis eClinical Tech News eClinical Technology EMA Executive Interviews FDA Enforcement FDA Guidance FDA Real-World Evidence FDA Regulation FDA Regulatory Strategy GCP Compliance GLP-1 Receptor Agonists Ketamine Therapy Oncology Trials Opinion Parkinson's Disease Platform Trials Psilocybin MDMA Psychedelic Clinical Trials PSYCH PULSE Real-World Evidence site activation Site Operations study startup Treatment-Resistant Depression
AstraZeneca and Alexion will present at the International Symposium on Amyloidosis (ISA) 2024, showcasing studies on their amyloidosis treatment...
Tennessee Cancer Specialists (TCS), an East Tennessee oncology group, has partnered with Sarah Cannon Research Institute (SCRI), a leading...
SpyBiotech and The University of Oxford have entered a research agreement to develop a vaccine against Epstein-Barr virus (EBV)....
Fulgent Pharma, a subsidiary of Fulgent Genetics, will present Phase 1 clinical data on FID-007, its lead therapeutic candidate...
The Middle East Town Hall at DIA Europe 2024 showcased significant Middle East clinical trial regulatory advancements across the...
Allez Health, a cutting-edge biosensor company specializing in continuous glucose monitoring (CGM), has secured $60 million in Series A+...
Gilead Sciences announced significant research findings to be presented at the European Association for the Study of the Liver...
The 2024 DIA Europe conference hosted a forward-thinking session titled “AI in Medicines Regulation: Beyond our Imagination.” The session...
The 2024 DIA Europe Conference brought together industry experts to explore the rapidly evolving medical device software and connected...
AngioDynamics, Inc. has obtained CE Mark approval in Europe for its AlphaVac F1885 System, enabling the non-surgical removal of...